NCT01480089

Surgical Pain Control With Ropivacaine by Atomized Delivery

Study Contact:

Study Phase:

PHASE4

Recruitment Status:

COMPLETED

NCT ID:

NCT01480089

Principal Investigator:

Study Type:

INTERVENTIONAL

Official Title:

Surgical Pain Control With Ropivacaine by Atomized Delivery

Summary

The purpose of this trial is to determine the effect of spraying a local anesthetic called Ropivacaine (numbing medicine) into the abdominal cavity prior to surgery. Ropivacaine is a local anesthetic used to block pain in the body. There are studies showing that Ropivacaine decreases the pain of surgery with minimally invasive (laparoscopic) appendix and gallbladder removal but has not been tried in robotic pelvic surgery.

Eligibility

Inclusion Criteria:

* Consent to undergo robotic assisted gynecologic or urologic surgery
* Between the ages of 18 and 75
* Able to consent, fill out study documents, and complete all study procedures and follow-up visits

Exclusion Criteria:

* Patients with an allergy to local anesthetics
* Patients with severe underlying cardiovascular, renal or hepatic disease
* Pregnant patients

Disease(s) and\or Condition(s)

Pain

Primary Purpose

PREVENTION

Intervention/Treatment

- Type: DRUG
- Name: Intraperitoneal Ropivacaine (AIR)
- Description: Ropivacaine 2 mg/kg per lean body mass up to no more than 200mg total dose will be atomized and delivered into the peritoneal cavity at the completion of surgery.
- Arm Group Labels: Intraperitoneal Ropivacaine(AIR)
- Type: DRUG
- Name: Atomized Intraperitoneal Saline (AIS)
- Description: Atomized saline will be administered to the peritoneal cavity at the completion of surgery.
- Arm Group Labels: Atomized Intraperitoneal Saline (AIS)

Sponsor

Loyola University